SGHC vs. AUPH
SGHC (Super Group (SGHC) Limited) and AUPH (Aurinia Pharmaceuticals Inc.) are both stocks. SGHC operates in Gambling (Consumer Cyclical), while AUPH operates in Biotechnology (Healthcare). Over the past 3 years, SGHC returned 59.82%/yr vs 16.72%/yr for AUPH. At a 0.28 correlation, their price movements are largely independent.
Performance
SGHC vs. AUPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SGHC achieves a 16.40% return, which is significantly higher than AUPH's -0.82% return.
SGHC
- 1D
- -2.46%
- 1M
- 3.30%
- YTD
- 16.40%
- 6M
- 22.02%
- 1Y
- 46.16%
- 3Y*
- 59.82%
- 5Y*
- —
- 10Y*
- —
AUPH
- 1D
- -0.19%
- 1M
- -1.31%
- YTD
- -0.82%
- 6M
- -0.19%
- 1Y
- 92.22%
- 3Y*
- 16.72%
- 5Y*
- 4.23%
- 10Y*
- 18.49%
SGHC vs. AUPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
SGHC Super Group (SGHC) Limited | 16.40% | 95.00% | 107.65% | 5.67% | -65.12% |
AUPH Aurinia Pharmaceuticals Inc. | -0.82% | 77.62% | -0.11% | 108.10% | -70.51% |
Correlation
The correlation between SGHC and AUPH is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jan 28, 2022 | 0.28 |
Fundamentals
SGHC:
$6.82B
AUPH:
$2.18B
SGHC:
$0.40
AUPH:
$2.15
SGHC:
33.42
AUPH:
7.37
SGHC:
1.41
AUPH:
0.00
SGHC:
3.17
AUPH:
7.37
SGHC:
9.98
AUPH:
3.84
SGHC:
$2.15B
AUPH:
$298.30M
SGHC:
$617.43M
AUPH:
$267.70M
SGHC:
$394.23M
AUPH:
$153.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SGHC vs. AUPH — Risk / Return Rank
SGHC
AUPH
SGHC vs. AUPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Super Group (SGHC) Limited (SGHC) and Aurinia Pharmaceuticals Inc. (AUPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SGHC | AUPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.03 | ||
| Sortino ratioReturn per unit of downside risk | -0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.38 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 1.23 | 5.83 | -4.60 |
| Martin ratioReturn relative to average drawdown | 2.82 | 12.68 | -9.86 |
Loading charts...
Drawdowns
SGHC vs. AUPH - Drawdown Comparison
The maximum SGHC drawdown since its inception was -76.02%, smaller than the maximum AUPH drawdown of -87.58%. Use the drawdown chart below to compare losses from any high point for SGHC and AUPH.
Loading charts...
Drawdown Indicators
| SGHC | AUPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.02% | -87.58% | +11.56% |
Max Drawdown (1Y)Largest decline over 1 year | -37.67% | -15.91% | -21.76% |
Max Drawdown (3Y)Largest decline over 3 years | -37.67% | -60.80% | +23.13% |
Max Drawdown (5Y)Largest decline over 5 years | — | -87.58% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -87.58% | — |
Current DrawdownCurrent decline from peak | -2.81% | -52.18% | +49.37% |
Average DrawdownAverage peak-to-trough decline | -45.51% | -49.21% | +3.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.39% | 7.30% | +9.09% |
Volatility
SGHC vs. AUPH - Volatility Comparison
Super Group (SGHC) Limited (SGHC) has a higher volatility of 11.00% compared to Aurinia Pharmaceuticals Inc. (AUPH) at 9.07%. This indicates that SGHC's price experiences larger fluctuations and is considered to be riskier than AUPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SGHC | AUPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.00% | 9.07% | +1.93% |
Volatility (6M)Calculated over the trailing 6-month period | 30.97% | 23.92% | +7.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.31% | 45.50% | +0.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.48% | 67.46% | -7.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.48% | 73.95% | -14.47% |
Dividends
SGHC vs. AUPH - Dividend Comparison
SGHC's dividend yield for the trailing twelve months is around 3.12%, while AUPH has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% |
SGHC Super Group (SGHC) Limited | 3.12% | 1.34% | 4.01% |
Financials
SGHC vs. AUPH - Financials Comparison
This section allows you to compare key financial metrics between Super Group (SGHC) Limited and Aurinia Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SGHC vs. AUPH - Profitability Comparison
SGHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Super Group (SGHC) Limited reported a gross profit of 140.00M and revenue of 578.00M. Therefore, the gross margin over that period was 24.2%.
AUPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.
SGHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Super Group (SGHC) Limited reported an operating income of 100.00M and revenue of 578.00M, resulting in an operating margin of 17.3%.
AUPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.
SGHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Super Group (SGHC) Limited reported a net income of 67.00M and revenue of 578.00M, resulting in a net margin of 11.6%.
AUPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.
Frequently Asked Questions
SGHC and AUPH have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SGHC has higher volatility (11.00%) compared to AUPH (9.07%). In terms of maximum drawdown, SGHC dropped -76.02% vs AUPH's -87.58%.
AUPH currently has the higher Sharpe Ratio (2.04 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SGHC and AUPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer